These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103. [The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains]. Schwartz E Prax Pneumol; 1971 May; 25(5):278-86. PubMed ID: 5556356 [No Abstract] [Full Text] [Related]
105. Naturally occurring quinones as potential bioreductive alkylating agents. Moore HW; Czerniak R Med Res Rev; 1981; 1(3):249-80. PubMed ID: 6810039 [No Abstract] [Full Text] [Related]
106. Trends in searching for antitumor compounds. Preobrazhenskaya MN Natl Cancer Inst Monogr; 1977 Mar; (45):195-205. PubMed ID: 337151 [No Abstract] [Full Text] [Related]
107. Glutathione S-transferases: role in alkylating agent resistance and possible target for modulation chemotherapy--a review. Waxman DJ Cancer Res; 1990 Oct; 50(20):6449-54. PubMed ID: 2208103 [No Abstract] [Full Text] [Related]
108. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1990; 11():29-44. PubMed ID: 2223396 [No Abstract] [Full Text] [Related]
109. Alkylating agents. Connors TA Cancer Chemother Biol Response Modif; 1992; 13():31-44. PubMed ID: 1389913 [No Abstract] [Full Text] [Related]
110. Alkylating agents. Berger NA Cancer Chemother Biol Response Modif; 1994; 15():32-43. PubMed ID: 7779588 [No Abstract] [Full Text] [Related]
111. Some pyrimidines of biological and medicinal interest. 3. Cheng CC; Roth B Prog Med Chem; 1971; 8(1):61-117. PubMed ID: 4935664 [No Abstract] [Full Text] [Related]